My length of service in general/urgent/traumatic, thoracic, abdominal surgery and surgical oncology is 40 years. I took part in 70 Scientific-Research, Technical-Research All-Russian and International Conferences and Congresses. I have 15 patents (20 inventions for screening, early detection, diagnosis and prognosis of malignancies) and 138 publications.

Dr. Mitsudomi is a Professor at the Division of Thoracic Surgery, Department of Surgery, Kindai University Faculty of Medicine in Osaka, Japan.
His research interests include surgical treatment of lung cancer and individualized treatment of lung cancer based on cancer genotypes such as EGFR mutations or ALK translocations. His group is also involved in studies of ctDNA and patient-derived organoids. He has published more than 400 papers that have featured in international peer-reviewed journals.
He is President of IASLC(2019-2021) and is an active member of AACR, ASCO, ESMO. He also served as President of Japanese Lung Cancer Society (2014-2018), Board of Director of Japanese Association of Chest Surgery (2013-2019), and Japanese Society of Medical Oncology (2013-2019). He is also a council member of the Japanese Surgical Society, Japanese Cancer Association, Japanese Association of Thoracic Surgery, Japanese Society of Clinical oncology, Japan Respiratory Society, etc.
Dr. Mitsudomi is an Associate Editor of Ann. Oncol. (2014-2019), Journal of Thoracic Oncology (2017-), Cancer Science (2007-), Surgery Today, and Lung Cancer (2008-2013). He is also an editorial board of Clinical Cancer Research.
He is a recipient of the Shinoi-Kawai Award from the Japan Lung Cancer Society (2001), JCA–Mauvernay Award from the Japanese Cancer Association (2005), Mary Matthews Award from the IASLC (2013), and Kiyoko and Paul Bourdarie-Goto Scientific Prize (2014).